目录肽产品
GLUC-008B
GLP-1/Glucagon-Like Peptide, human
His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly
His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly
Size：1.0
P1(RMB)：1011
MW：4169.6
One letter sequence：HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
Molecular Formula：C186H275N51O59
Description：GLP, synthesized by posttranslational processing of proglucagon in the intestine and pancreas, plays an important role in metabolic homeostasis. It is capable of converting intestinal epithelial cells into insulin-producing cells, thus serving as a new putative therapeutic compound for the treatment of diabetes mellitus.
Literature Reference：G.I. Bell et al., Nature, 304, 368 (1983)
Cas：[87805-34-3]
P1(RMB)：1011
MW：4169.6
One letter sequence：HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
Molecular Formula：C186H275N51O59
Description：GLP, synthesized by posttranslational processing of proglucagon in the intestine and pancreas, plays an important role in metabolic homeostasis. It is capable of converting intestinal epithelial cells into insulin-producing cells, thus serving as a new putative therapeutic compound for the treatment of diabetes mellitus.
Literature Reference：G.I. Bell et al., Nature, 304, 368 (1983)
Cas：[87805-34-3]
